Amlodipine Besylate
Product Images NDC 43353-251
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 43353-251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena Pharma Solutions (TN)
Fig1 (Fig1)
This appears to be output from a statistical analysis of some event data. The "P-value=0.003" suggests that there is strong evidence of a statistically significant difference between the groups being compared. The "Hazard Ratio=0691" suggests that the risk of the event occurring is lower in one group compared to the other. The "95% Cl=(0.54, 0.88)" provides a confidence interval for the hazard ratio. The time points listed could indicate the duration of the study or the time at which events occurred. Overall, this appears to be a summary of the statistical results from an event study.*
Fig2 (Fig2)
This text provides a summary of a study that compares the effectiveness of Favars Amladipine to Placebo in patients with baseline sitting SEP of 120 mmHig for various factors such as Gender, Baseline Vessel Disease, etc. The study includes 984 males and 334 females, with multiple baseline vessel diseases found in 1315 patients, amongst others. The results are presented in a graph that depicts the hazard ratio with a 95% confidence interval for different time intervals.*
Structure (Ima)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.